QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.
Our business is inspired by our values:
FGFR=fibroblast growth factor receptor.
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.
Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.
To learn more about our story and company culture, visit us at https://www.qedtx.com/ | https://bridgebio.com
The Manager/Sr. Manager, Medical Affairs Operations will be responsible for the project management, daily operation, and support across a variety of critical initiatives for the Medical Affairs organization in preparation to the launch preparation activities of infigratinib, QED’s phase 3 leading asset. The successful candidate will have an opportunity to design and manage the Company’s Medical Affairs Group’s Operational infrastructure. This role reports directly to the Head of Medical Affairs and offers a unique opportunity to work cross-functionally with internal and external stakeholders and will be a key member of the Medical Affairs Management Team (MALT). You will directly contribute to the overall success of the organization.
No matter your role at BridgeBio, successful team members are:
We will not accept unsolicited resumes from agencies. Please do not send agency resumes to our website or BridgeBio and affiliating employees.
TASQ Staffing Solutions
Sobi - Swedish Orphan Biovitrum AB (publ)
esqLABS GmbH
Eli Lilly and Company